Scientists at Ångstron Materials (a spin-off from Nanotek Instruments, Inc.) have developed a new class of nanomaterials now commonly referred to as nano-scaled graphene plates or platelets (NGPs) and NGP nanocomposites.
ANP's mission is to develop cutting-edge technology platforms at the nano/bio interface and apply them in market sectors such as diagnostics/biodetection, protein/drug discovery, therapeutics, chem/bio defense, and homeland security.
The Multiphysics simulation tool addresses nanotechnology simulation requirements covering ion optics, and electrostatic calculations associated with field emission tips and carbon nanotube structures.
The company develops biomedical nanoparticle technology and products for research and treatment of human disease. They are developing NanoElectroPlex™, a proprietary tissue selective nanoparticle platform technology based on biodegradable macromolecular carriers.
ApoLife has developed platform yeast expression technologies for accelerated development of therapeutic antibodies (glycosylated and aglycosylated), antibody fragments, fusion proteins and next generation antibodies and subunit vaccines through its proprietary Twin Cassette yeast system.
Applied Biosystems Group serves the life science industry and research community by developing and marketing instrument-based systems, consumables, software, and services. Customers use these tools to analyze nucleic acids (DNA and RNA), small molecules, and proteins to make scientific discoveries and develop new pharmaceuticals.
The company utilizes its proprietary knowledge of high performance lasers, high-voltage electronics, advanced adaptive optics and atmospheric and plasma energy interactions to develop cutting edge technologies to deliver innovative solutions for critical military missions.